Zydus Lifesciences Limited

NSEI:ZYDUSLIFE Stock Report

Market Cap: ₹1.1t

Zydus Lifesciences Management

Management criteria checks 2/4

Zydus Lifesciences' CEO is Sharvil Patel, appointed in Apr 2017, has a tenure of 7.17 years. total yearly compensation is ₹262.50M, comprised of 68.6% salary and 31.4% bonuses, including company stock and options. directly owns 0.001% of the company’s shares, worth ₹16.41M. The average tenure of the management team and the board of directors is 6.1 years and 9.1 years respectively.

Key information

Sharvil Patel

Chief executive officer

₹262.5m

Total compensation

CEO salary percentage68.6%
CEO tenure7.2yrs
CEO ownership0.001%
Management average tenure6.1yrs
Board average tenure9.1yrs

Recent management updates

Recent updates

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

May 25
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Mar 18
Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Feb 28
Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Feb 12
Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Dec 27
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

Dec 06
Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Aug 23
With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Jul 17
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Jul 15
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Jun 24
Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

May 21
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

Feb 15
Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Nov 13
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Aug 09
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 25
Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Jul 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

Jul 07
Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

CEO Compensation Analysis

How has Sharvil Patel's remuneration changed compared to Zydus Lifesciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

₹38b

Dec 31 2023n/an/a

₹30b

Sep 30 2023n/an/a

₹28b

Jun 30 2023n/an/a

₹25b

Mar 31 2023₹263m₹180m

₹20b

Dec 31 2022n/an/a

₹21b

Sep 30 2022n/an/a

₹20b

Jun 30 2022n/an/a

₹22b

Mar 31 2022₹200m₹180m

₹22b

Dec 31 2021n/an/a

₹23b

Sep 30 2021n/an/a

₹23b

Jun 30 2021n/an/a

₹23b

Mar 31 2021₹263m₹180m

₹22b

Dec 31 2020n/an/a

₹18b

Sep 30 2020n/an/a

₹17b

Jun 30 2020n/an/a

₹13b

Mar 31 2020₹250m₹247m

₹12b

Dec 31 2019n/an/a

₹12b

Sep 30 2019n/an/a

₹14b

Jun 30 2019n/an/a

₹17b

Mar 31 2019₹250m₹248m

₹18b

Dec 31 2018n/an/a

₹20b

Sep 30 2018n/an/a

₹20b

Jun 30 2018n/an/a

₹21b

Mar 31 2018₹250m₹248m

₹18b

Compensation vs Market: Sharvil's total compensation ($USD3.14M) is above average for companies of similar size in the Indian market ($USD944.35K).

Compensation vs Earnings: Sharvil's compensation has increased by more than 20% in the past year.


CEO

Sharvil Patel (45 yo)

7.2yrs

Tenure

₹262,500,000

Compensation

Dr. Sharvil Pankajbhai Patel has been Managing Director of Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) since April 1, 2017 and previously served as its Joint Managing Director...


Leadership Team

NamePositionTenureCompensationOwnership
Sharvil Patel
MD & Executive Director7.2yrs₹262.50m0.0015%
₹ 16.4m
Ganesh Nayak
COO & Executive Director6.9yrs₹120.00m0.035%
₹ 386.3m
Punit Patel
President & CEO of Americaless than a yearno datano data
Nitinkumar Parekh
Chief Financial Officerno data₹54.31mno data
Arvind Bothra
Head of Investor Relationsno datano datano data
Dhaval Soni
Company Secretary & Compliance Officer5.3yrs₹2.09mno data

6.1yrs

Average Tenure

Experienced Management: ZYDUSLIFE's management team is seasoned and experienced (6.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sharvil Patel
MD & Executive Director26.8yrs₹262.50m0.0015%
₹ 16.4m
Ganesh Nayak
COO & Executive Director6.9yrs₹120.00m0.035%
₹ 386.3m
Pankaj Patel
Non-Executive Chairman29.1yrs₹1.60m74.98%
₹ 837.1b
Apurva Diwanji
Independent Director8.1yrs₹4.60mno data
Mukeshbhai Patel
Non-Executive Non-Independent Director26.8yrs₹4.80m0.0012%
₹ 13.0m
Bhadresh Shah
Independent Director5.5yrs₹4.60mno data
Dharmishtaben Raval
Non-Executive Independent Director10.1yrs₹4.50mno data
Nitin Desai
Non-Executive Independent Director13.1yrs₹4.30m0.046%
₹ 517.3m
Akhil Monappa
Independent Director1.6yrs₹1.20mno data
Upasana Konidela
Independent Director1.6yrs₹1.20mno data

9.1yrs

Average Tenure

69yo

Average Age

Experienced Board: ZYDUSLIFE's board of directors are considered experienced (9.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.